Omega Healthcare Investors, Inc.

The company holds $26.1M in cash, though total debt stands at $4.45B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $508.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 12.6%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 5.0% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $878.2M (2022) to $1.19B (2025), reflecting a 36% increase over the period.

OHI's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Omega Healthcare Investors, Inc. and its sector.